The operating envelope: what a living actuator needs to keep working

A living actuator is not a component with an operating range. It is an organism with a life support requirement, and the distinction matters the moment you try to write a datasheet for one.

An electromagnetic actuator has a temperature range, a duty cycle and an MTBF. A muscle construct has an environment it must remain inside continuously — not while operating, but always, including while idle, while shipping and while your device is switched off. Leave that envelope and the part does not derate. It dies, irreversibly, and the replacement takes four to six weeks to grow.

This page states what that envelope actually is, what published devices achieved inside it, and the one documented exception that escapes it.

The mammalian envelope

Every mammalian biohybrid construct in the published literature — skeletal or cardiac, mouse or human — operates inside approximately this box.

Read that table as a systems requirement and the consequence is stark: an untethered mammalian biohybrid device is carrying an incubator. Not metaphorically — a heater, a buffered fluid reservoir, a sterile barrier and a fluid exchange path. That payload is why almost every published mammalian biohybrid robot swims in a dish rather than walking across a bench.

What published devices actually achieved

The lifetime problem, stated honestly

Notice how many cells in that final column say “not stated as a headline figure”. That is not an extraction failure on our part. Biohybrid papers overwhelmingly report peak performance rather than endurance, because the demonstration is the contribution and the durability is somebody else’s problem.

The one group that made durability the contribution tells you why. Morimoto and colleagues state the problem directly: it has been difficult to achieve both large and long-term actuation, because skeletal muscle tissue spontaneously shrinks over the course of culture. Their antagonistic-pair architecture is a fix for that — the two tissues hold each other in tension so neither collapses — and the result was roughly one week of function with ~90° of joint rotation.

One week is the honest planning figure for an untethered skeletal biohybrid device, and it comes from the paper that was specifically trying to beat it.

For tethered constructs sitting in a well, the horizon is longer but not unbounded. Smith and colleagues tracked engineered muscle force across a 14-day window and found primary human tissues still increasing at day 14 while their iPSC-derived counterparts had already peaked — so even “still improving” and “already declining” are cell-source-dependent within the same two weeks.

What does not exist anywhere in this literature: a mean time to failure, a survival curve, a duty-cycle-dependent degradation model, or a cycles-to-failure figure of the kind any mechanical actuator carries as a matter of course. If your system engineering needs those numbers, you will be generating them yourself, and you should budget for that as a work package rather than assuming a supplier or a paper will provide them.

The one exception, and its price

Insect dorsal vessel tissue is the only published substrate that escapes the incubator, and it escapes it comprehensively: Akiyama and colleagues’ microrobot operated at room temperature, with no CO₂ incubator and no external stimulation, driven by spontaneous rhythmic contraction. Their follow-on work went further and built an atmospheric-operable bioactuator — the tissue packaged with a small volume of medium inside a capsule, with microtweezer arms projecting above the medium surface, deforming in air.

That is an untethered living actuator working outside a culture facility. Nothing in the mammalian literature comes close.

The price is force. 20 µN for a whole dorsal vessel, against 7.05 mN for the best C2C12 construct — roughly three orders of magnitude. And locomotion at 3.5 × 10⁻² µm/s for the prototype, improved to 3.5 µm/s in the refined device, is slow by any standard.

The second price is supply, and it is total: there is no commercial source of insect dorsal vessel tissue. Every published use is a laboratory dissection from a maintained insect colony. That makes this a collaboration question rather than a procurement one, and it is the reason the route stays rare despite being the only answer to a question the whole field keeps asking.

Designing against this envelope

Four design consequences follow directly, and they are worth settling before any cells are ordered.

1. Decide tethered or untethered first, because it selects your substrate. Tethered — a device that lives in a dish, on a stage, in an incubator — gives you the full mammalian force range and the whole published literature. Untethered at ambient means insect tissue at 20 µN, or carrying life support. There is no third option in the published record.

2. Duty cycle is a maturation decision as much as an actuation one. Chronic pacing is the largest documented lever on force: one week of intermittent 1 Hz stimulation roughly tripled tetanic force in human myobundles. Your stimulation budget is doing two different jobs — growing the muscle and moving the device — and they want different waveforms.

3. Anchor compliance is part of the operating condition, not the fixture. Posts that are too soft bend under passive tension until active contraction cannot be resolved at all; posts that are stiffer measured nearly double the twitch force from identical tissue. Specify stiffness with a tolerance, and record it with every measurement, or your own results will not be comparable to each other.

4. Shipping is part of the envelope. This is where myriamed’s product is quietly notable: the myrTissue line ships at ambient temperature with a certificate of analysis per batch, at EUR 1,400 for a single tissue. Ambient shipping of a contractile construct is a genuine logistics achievement, and it is the reason buying finished tissue is now a real option rather than a theoretical one — see the culture requirements comparison for how that changes the build-versus-buy answer.

What to write in a specification

If you are asking a laboratory to build you an actuator, these are the environmental terms that must be in the document. Their absence is the most common reason two quotes cannot be compared.

• Operating temperature and atmosphere the device must tolerate, including during transport and storage, not only during actuation.
• Required functional lifetime, stated in days of useful contraction — and be aware that anything beyond about a week for an untethered skeletal construct is outside the published demonstrated range, so it is a research objective rather than a build order.
• Duty cycle, separating maturation pacing from actuation.
• Anchor stiffness with a tolerance, because it is part of the measurement.
• Acceptance test conditions — the temperature, medium, stimulation protocol and post stiffness under which the force will be verified. A force number without these is not testable, and an untestable acceptance criterion is not an acceptance criterion.

How we can help

We route actuator specifications to laboratories that can build them and return the quotes normalised, including the environmental and acceptance terms above rather than force alone. Where a requirement sits outside the published envelope — an untethered mammalian device expected to run for a month, say — we will tell you that before the purchase order, with the papers that establish where the boundary currently is. That is more useful than a quote, because a quote against an undemonstrated requirement is a quote for a research programme wearing a delivery date.